Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-04-01
|
| Series: | Infectious Diseases and Therapy |
| Online Access: | https://doi.org/10.1007/s40121-025-01150-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850102421894725632 |
|---|---|
| author | Javier Díez-Domingo Róbert Simkó Giancarlo Icardi Chan Poh Chong Céline Zocchetti Olga Syrkina Siham Bchir Isabelle Bertrand-Gerentes |
| author_facet | Javier Díez-Domingo Róbert Simkó Giancarlo Icardi Chan Poh Chong Céline Zocchetti Olga Syrkina Siham Bchir Isabelle Bertrand-Gerentes |
| author_sort | Javier Díez-Domingo |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b3af3231ee7f447ab7fabe3a41a04e54 |
| institution | DOAJ |
| issn | 2193-8229 2193-6382 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Infectious Diseases and Therapy |
| spelling | doaj-art-b3af3231ee7f447ab7fabe3a41a04e542025-08-20T02:39:44ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822025-04-011461379138010.1007/s40121-025-01150-1Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter StudyJavier Díez-Domingo0Róbert Simkó1Giancarlo Icardi2Chan Poh Chong3Céline Zocchetti4Olga Syrkina5Siham Bchir6Isabelle Bertrand-Gerentes7Vaccine Research Department, FISABIOFuturenest Clin. Res. LtdDepartment of Health Sciences, University of Genoa-Hygiene Unit, San Martino Policlinico HospitalDepartment of Paediatrics, KTP-National University Children’s Medical Institute, National University HospitalIsabelle Betrand-Gerentes, Global MedicalPatient Safety and Pharmacovigilance, Sanofi R&DGlobal Biostatistical Sciences, Sanofi VaccinesIsabelle Betrand-Gerentes, Global Medicalhttps://doi.org/10.1007/s40121-025-01150-1 |
| spellingShingle | Javier Díez-Domingo Róbert Simkó Giancarlo Icardi Chan Poh Chong Céline Zocchetti Olga Syrkina Siham Bchir Isabelle Bertrand-Gerentes Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study Infectious Diseases and Therapy |
| title | Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study |
| title_full | Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study |
| title_fullStr | Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study |
| title_full_unstemmed | Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study |
| title_short | Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study |
| title_sort | correction immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine versus nimenrix in healthy adolescents a randomized phase iiib multicenter study |
| url | https://doi.org/10.1007/s40121-025-01150-1 |
| work_keys_str_mv | AT javierdiezdomingo correctionimmunogenicityandsafetyofaquadrivalentmeningococcalconjugatevaccineversusnimenrixinhealthyadolescentsarandomizedphaseiiibmulticenterstudy AT robertsimko correctionimmunogenicityandsafetyofaquadrivalentmeningococcalconjugatevaccineversusnimenrixinhealthyadolescentsarandomizedphaseiiibmulticenterstudy AT giancarloicardi correctionimmunogenicityandsafetyofaquadrivalentmeningococcalconjugatevaccineversusnimenrixinhealthyadolescentsarandomizedphaseiiibmulticenterstudy AT chanpohchong correctionimmunogenicityandsafetyofaquadrivalentmeningococcalconjugatevaccineversusnimenrixinhealthyadolescentsarandomizedphaseiiibmulticenterstudy AT celinezocchetti correctionimmunogenicityandsafetyofaquadrivalentmeningococcalconjugatevaccineversusnimenrixinhealthyadolescentsarandomizedphaseiiibmulticenterstudy AT olgasyrkina correctionimmunogenicityandsafetyofaquadrivalentmeningococcalconjugatevaccineversusnimenrixinhealthyadolescentsarandomizedphaseiiibmulticenterstudy AT sihambchir correctionimmunogenicityandsafetyofaquadrivalentmeningococcalconjugatevaccineversusnimenrixinhealthyadolescentsarandomizedphaseiiibmulticenterstudy AT isabellebertrandgerentes correctionimmunogenicityandsafetyofaquadrivalentmeningococcalconjugatevaccineversusnimenrixinhealthyadolescentsarandomizedphaseiiibmulticenterstudy |